Turnover: 2.8 billion EUR (2023)
Country: France
Founded in 1951, Pierre Fabre is a French pharmaceutical and dermo-cosmetics laboratory. The latter accounts for 60% of its sales, making it the world's 2nd largest group in the dermo-cosmetics market.
The only international dermo-cosmetics company active in the medical dermatology market
The company distributes its products in 116 countries and currently has subsidiaries in 41 countries worldwide
60% of sales generated outside France
9600 employees worldwide
Pierre Fabre is owned by the Pierre Fabre Foundation
The company is headquartered in Castres
News
Pierre Fabre sells its immuno-oncology research center 02/09/2024
- - The Pierre Fabre Group has entered into exclusive negotiations to sell its Saint-Julien-en-Genevois R&D center to pharmaceutical subcontractor Jubilant Biosys.
- - The center employs 35 people.
- - The center was set up in 1990 and specializes in immuno-oncology, notably in the development of monoclonal or conjugated antibodies and immunomodulating biologics.
- - Jubilant Biosys, which employs 2,300 people in India, Italy and the USA, carries out contract R&D for pharmaceutical groups.
- - The site also included a 45-strong monoclonal antibody clinical batch production unit, which was sold in 2020 to subcontractor Fareva, and later to GTP Bioways, acquired by Italy's Olon.
- - Pierre Fabre is discontinuing immuno-oncology research to focus on targeted cancer therapies, with an oncology R&D budget of 100 million euros per year and revenues of 500 million euros.
- - The group has transferred all its research to the Toulouse Oncopôle, which employs 650 people, with 40 new hires in 2023 and 30 planned for 2024.
- - Pierre Fabre's sales in 2023 will be 2.83 billion euros, up 6%, with 57% generated in dermocosmetics.
Pierre Fabre Laboratories acquire a stake in start-up MiYé 08/10/2023
- Start-up MiYé was co-founded in 2020 by Caroline de Blignières and Anna Oualid.
- MiYé specializes in women's hormonal well-being.
- The start-up distributes a range of 13 products, including 5 dietary supplements and 8 dermo-cosmetics.
- The Pierre Fabre Group also became a majority shareholder in Ladrôme Laboratoire in 2021, and sole shareholder in Même Cosmetics a year later.
- Pierre Fabre's strategy is to strengthen its brand portfolio by acquiring targeted stakes in companies operating in specific markets.
- The MiYé brand is currently distributed in 200 points of sale.
Pierre Fabre takes control of Même Cosmetics 26/04/2023
- The Pierre Fabre Group has acquired Même Cosmetics, a leading French dermo-cosmetics brand for patients suffering from the side effects of cancer treatments.
- Même had already been part of the Pierre Fabre Group for five years, with a minority stake.
- The company generates over 50% of its sales in the dermo-cosmetics sector.
- Même Cosmetics offers 46 products available in 4,800 pharmacies and parapharmacies, as well as on its own online sales site.
- The brand is present in ten European countries, including Germany, Belgium, Switzerland, Morocco, Spain, Italy, Romania, the Czech Republic and China.
- Pierre Fabre is the world's second-largest dermo-cosmetics laboratory and France's 2nd-largest private pharmaceutical group.
- The group is the market leader in France, ahead of L'Oréal.
- Pierre Fabre generates 69% of its sales internationally, with France and China its main markets.
- The company has 43 subsidiaries worldwide and operates in three business sectors: dermo-cosmetics, family health and pharmaceuticals.
- The Group employs 9,600 people, including 5,300 in France.
- Pierre Fabre achieved sales of 2.7 billion euros (up +10% in one year).
- Pierre Fabre's objective is to achieve sales of 3.5 billion euros by 2025.
Pierre Fabre expands its dermo-cosmetics range with the Même brand 20/04/2023
- Même Cosmetics was founded in 2015. The company employs 40 people.
- Pierre Fabre had acquired 15% of Même Cosmetics at the end of 2017.
- The products are available in 4,800 pharmacies and parapharmacies in France and ten other countries, as well as online.
- Même Cosmetics generates 15% of its sales from exports.
- The Pierre Fabre Group has 9,600 employees.
- By 2022, Pierre Fabre's sales have risen by 10.1% to 2.7 billion euros.
- Growth in dermo-cosmetics is 11.7%, while that of pharmaceuticals is 8%.
- Dermo-cosmetics represent 55% of Pierre Fabre's sales, and oncology 17%.
- China has become Pierre Fabre's second largest market, after France.
Pierre Fabre has bought back the rights to Urovant's vibégron for $75 million. 06/07/2022
- Pierre Fabre has just signed a licensing agreement with Urovant Sciences, a subsidiary of US biotech Sumitovant Biopharma, for vibegron for the treatment of overactive bladder.
- Urovant to receive up to $75 million
- The aim is to sell its products in Europe, including the UK and Switzerland, certain French-speaking countries in sub-Saharan Africa, Turkey and certain Eastern European countries.
- The two entities will share responsibility for European clinical trials of vibegron in pediatric populations.
- Worldwide, 546 million people over the age of twenty are affected by OAB.
Financial Data
DUNS: 662006170
Legal Name: PIERRE FABRE SA
Address: 12 AV HOCHE , 75008 PARIS 8
Number of employees: Entre 500 et 999 salariés (2020)
Capital: 272 416 658 EUR
Financial Data:
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Turnover | 273 800 000 | 209 000 000 | 186 000 000 | 189 000 000 | 175 000 000 | 168 000 000 | 160 000 000 |
| Gross margin (€) | 345 000 000 | 262 100 000 | 261 800 000 | 240 200 000 | 213 100 000 | 186 400 000 | 171 600 000 |
| EBITDA (€) | 36 400 000 | 24 800 000 | 24 600 000 | 90 000 000 | 1 500 000 | 4 800 000 | 7 800 000 |
| Operating profit (€) | 14 800 000 | 5 600 000 | 6 500 000 | -8 700 000 | 1 000 000 | -2 100 000 | 500 000 |
| Net profit (€) | 176 000 000 | 112 000 000 | 49 000 000 | -20 000 000 | 36 000 000 | 63 000 000 | 71 000 000 |
| Turnover growth rate (%) | 30,4 | 12,4 | -1,3 | 7,7 | 4,2 | 5 | - |
| Ebitda margin rate (%) | 13,3 | 11,8 | 13,2 | 47,5 | 0,9 | 2,8 | 4,9 |
| Operating margin rate (%) | 5,4 | 2,7 | 3,5 | -4,6 | 0,6 | -1,2 | 0,3 |
| Working Capital (turnover days) | 308,9 | 473,8 | 680,4 | 913,8 | 833,7 | 715,7 | 922,9 |
| Working Capital requirements (turnover days) | 88,7 | 81,2 | 21,9 | 2,3 | -2,9 | 8,4 | 41,4 |
| Net margin (%) | 64,3 | 53,4 | 26,2 | -10,6 | 21,8 | 37,4 | 44,2 |
| Added value / Turnover (%) | 53,5 | 52 | 49 | 48 | 48,2 | 44,7 | 45,5 |
| Wages and social charges (€) | 113 300 000 | 172 200 000 | 80 000 000 | 78 600 000 | 83 600 000 | - | - |
| Salaries / Turnover (%) | 41,4 | 82 | 42,8 | 41,5 | 47,6 | - | - |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président du conseil d'administration | Frédéric Roch | Doliveux | 68 | |
| Directeur général | Eric | Ducournau | 57 | |
| Administrateur | Marie-France | Marchand | 71 | |
| Administrateur | Eduardo | Sanchiz | 68 | |
| Administrateur | Rachel | Marouani | 53 | |
| Administrateur | Jean-Laurent | Bonnafe | 63 | |
| Administrateur | Isabelle | Girolami | 60 | |
| Administrateur | Marie-Anne | Helfi | 59 | |
| Administrateur | Olivier | SADRAN | 55 | |
| Administrateur | Jean-François | COURET | 51 | |
| Administrateur représentant les salariés | Agathe | Colombie | 52 | |
| Administrateur représentant les salariés | Alexandre | Giraudon | 41 |
Studies mentioning this company
The beauty salon market - Belgium
Other companies mentioned:
- Pierre Fabre
- Louis Widmer Belgium
- Insituut Daphnys
- Institut Cinyhia
- Emotion
- Groupe Rocher (Yves Rocher)
The dermocosmetics market - France
Other companies mentioned:
- Beiersdorf
- La Roche-Posay
- Nuxe
- Estée Lauder
- Too fruit
- Sephora
- Lucette (Hivency)
- Marionnaud France
- AS Watson
- La Crème Libre
- NAOS Bioderma
- Caudalie
- Pierre Fabre
- Galderma
- Groupe Rocher (Yves Rocher)
- Clarins Groupe
- Ieva Group
- A Derma (Pierre Fabre Groupe)
- Cible Skin
- Uriage (Puig Groupe)
- Sanex (Colgate-Palmolive)
- Klorane (Pierre Fabre Dermocasmétique)
- Laboratoire Native- Alès Groupe (marques Phyto, Lierac, Roger & Gallet, Jowae)
- Lierac (Laboratoire Native)
- Mixa (L'Oréal))
- Nivea (Beiersdorf)
- Topicrem - Mayoly Spindler
- Roger&Gallet (Laboratoire Native)
- Z&MA
- Institut Esthederm (Naos)
- Galénic
- Codexial Dermatologie
- Eucerin
- Ducray
- Noreva
- Embryolisse
- SVR Laboratoires
- Grown Alchemist (L'Occitane Groupe)
- BeauTerra
- Havea Group
- Havea Groupe Biolane
- Biocodex
- Dr Pierre Ricaud (Rocher Groupe)
- Alvadiem
- Olala cosmetics - EQAM
- Expanscience
- RoC Skincare
- Novexpert
The cosmetics market - France
Other companies mentioned:
- Robertet
- Alkos Cosmétiques Groupe
- Alpol Cosmétiques
- Codexial Dermatologie
- Fareva
- Laboratoires Lebeau
- Laboratoires Prevost
- Laboratoire Science & Nature
- Lorcos
- Phytocosma
- SICAF
- Skinlys
- Technature
- Sephora
- Nocibé (Douglas Groupe)
- Marionnaud France
- Caudalie
- Pierre Fabre
- Galderma
- Weleda
- Revlon
- Groupe Rocher (Yves Rocher)
- Rituals Cosmetic
- Clarins Groupe
- Beiersdorf
- Berdoues
- Sisley
- Unbottled
- Rogé Cavaillès
- Cofatech
- Gilbert Groupe
- Aesop (L'Oréal groupe)
- Vabel Groupe - Sarbec Cosmetics
- La Prairie
- Anjac Health and Beauty
- Lorience Groupe
- Darphin (Estée Lauder)
The Parapharmacy Market - France
Other companies mentioned:
- Parashop Diffusion
- Nocibé (Douglas Groupe)
- Weleda
- Pharmavie
- Giphar groupe
- Elsie Santé
- Lemoine Groupe
- Sanofi Aventis
- Pierre Fabre
- Eau Thermale d'Avène (Pierre Fabre Groupe)
- NAOS Bioderma
- Pharmazon
- Pharm Upp
- Objectif Pharma
- Mediprix
- Hygie 31- Laf Santé Lafayette
- Docmorris DoctiPharma
- Atida Santé Discount
- Paraland – BeautéLand
- Nepenthès
The dermocosmetics market - Italy
Other companies mentioned:
- L'Oréal Italia
- EuroItalia
- Manetti & Roberts
- GOTTARDO S.P.A.
- Douglas
- KIKO Milano
- Pierre Fabre